UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 48 filers reported holding UNUM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,055,000 | -45.1% | 732,967 | 0.0% | 0.00% | – |
| Q2 2019 | $1,920,000 | -40.3% | 732,967 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $3,218,000 | -0.2% | 732,967 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,225,000 | -60.3% | 732,967 | -7.2% | 0.00% | -50.0% |
| Q3 2018 | $8,132,000 | -31.8% | 789,467 | -4.9% | 0.00% | -33.3% |
| Q2 2018 | $11,916,000 | +29.2% | 830,364 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $9,225,000 | – | 830,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 3,361,535 | $48,238,000 | 21.23% |
| New Leaf Venture Partners, L.L.C. | 1,795,545 | $25,766,000 | 6.22% |
| SECTORAL ASSET MANAGEMENT INC | 1,081,545 | $15,520,000 | 1.74% |
| SABBY MANAGEMENT, LLC | 581,303 | $8,342,000 | 1.29% |
| Novo Holdings A/S | 665,181 | $9,545,000 | 0.96% |
| COWEN INC. | 581,255 | $8,341,000 | 0.35% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 225,000 | $3,229,000 | 0.08% |
| WASATCH ADVISORS LP | 267,625 | $3,840,000 | 0.05% |
| THOMPSON DAVIS & CO., INC. | 866 | $12,000 | 0.03% |
| FIL Ltd | 1,138,274 | $16,334,000 | 0.02% |